Factor | HHV6 n(%) | CMV n(%) | Both n(%) | Negative n(%) | p value |
---|---|---|---|---|---|
Age | Â | Â | Â | Â | Â |
< 9 y n = 25 | 3(12) | 3(12) | 7(28) | 12(48) | 0.395 |
≥9 Y n = 25 | 3(12) | 4(16) | 3(12) | 15(60) |  |
Sex | Â | Â | Â | Â | Â |
M: n = 32 | 3(9) | 4(13) | 7(22) | 18(56) | 0.670 |
F: n = 18 | 3(17) | 3(17) | 3(17) | 9(50) | Â |
Stage | Â | Â | Â | Â | Â |
I+II (n = 25) | 3(12) | 5(20) | 4(16) | 13(52) | 1.000 |
III+IV (n = 25) | 4(16) | 3(12) | 5(20) | 13(52) | Â |
Phase of therapy | Â | Â | Â | Â | Â |
Induction: n = 24 | 2(8) | 6(25) | 5(21) | 11(46) | Â |
Maintenance: n = 23 | 3(13) | 1(4) | 3(13) | 16(70) | 0.034 |
Salvage: n = 3 | 1(33) | 0(0) | 2(67) | 0(0) | Â |
Status of disease | Â | Â | Â | Â | Â |
CR+PR: n = 42 | 5(12) | 6(14) | 6(14) | 25(60) | 0.021 |
SD+PD: n = 8 | 2(25) | 1(13) | 4(50) | 1 (13) | Â |
Outcome | Â | Â | Â | Â | Â |
Af: n = 38 | 4(11) | 6(16) | 6(16) | 22(59) | Â |
Ad: n = 10 | 1(10) | 0(0) | 4(40) | 5(50) | * |
D: n = 2 | 1(50) | 1(50) | 0(0) | 0(0) | Â |